Published on FiercePharma (http://www.fiercepharma.com)

Study: Anemia meds double clot risk

By tracy

Created Nov 11 2009 - 11:23am

A decade-long study of 55,000 cancer patients adds to mounting evidence that anemia drugs such as Amgen's Epogen and Johnson & Johnson's Procrit boost the risk of blood clots significantly. Report [1]

Amgen
Epogen
Johnson & Johnson
Procrit

Source URL: http://www.fiercepharma.com/story/study-anemia-meds-double-clot-risk/2009-11-11

Links:
[1] http://www.reuters.com/article/rbssHealthcareNews/idUSN1032780720091110